Zyprexa Tablet, Orally Disintegrating
Product Images NDC 61269-652

12 FDA label images from H2-pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Zyprexa (NDC 61269-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zyprexa F001 V1)

Chemical Structure (Zyprexa F001 V1)
Chemical structure of olanzapine, the active ingredient in Zyprexa. The diagram depicts the molecular arrangement with ring systems including a thiazepine ring and methyl groups attached to the molecule.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
Zyprexa Olanzapine Tablets 2.5 mg label for a 30-tablet package distributed by H2-Pharma LLC. The label includes dosage strength, directions to dispense the enclosed Medication Guide, and storage instructions. A small tablet image with "ZYP 2.5" is shown, along with a barcode and NDC 61269-630-30.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
Label for Zyprexa 5 mg Olanzapine tablets, a prescription oral tablet product by H2-Pharma LLC. The label indicates a 30 tablet count with NDC 61269-631-30, featuring a white round tablet marked 'ZYP 5'. Storage and handling instructions, barcode, and manufacturer information are also present.*
FDA Label Image

Principal Display Panel (7.5 mg Tablet Bottle Label)

Principal Display Panel (7.5 mg Tablet Bottle Label)
Label for Zyprexa 7.5 mg oral tablets containing Olanzapine. The label states a bottle count of 30 tablets, includes the NDC 61269-632-30, and mentions the distributor H2-Pharma LLC. The Cheplapharm logo appears at the bottom, along with storage and usage instructions and a warning about tamper-evident seals.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Zyprexa 10 mg tablets label shows a box of 30 tablets of Olanzapine tablets for oral use. The label includes the NDC 61269-633-30, instructions to dispense the Medication Guide, and storage directions. It is distributed by H2-Pharma LLC and licensed by Cheplapharm.*
FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Principal Display Panel (15 mg Tablet Bottle Label)
Label for Zyprexa 15 mg oral tablets containing Olanzapine, distributed by H2-Pharma LLC. The label indicates a package of 30 tablets and includes instructions to dispense the enclosed Medication Guide, storage conditions, and a barcode. The product is prescription-only (Rx).*
FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Principal Display Panel (20 mg Tablet Bottle Label)
Zyprexa 20 mg Olanzapine Tablets label showing a bottle containing 30 oral tablets. The label includes the proprietary name Zyprexa with Olanzapine as the generic, strength of 20 mg, and instructions to dispense the enclosed Medication Guide. It is distributed by H2-Pharma LLC and includes storage and handling instructions, a picture of an oval tablet marked ZYP 20, and a barcode with NDC 61269-635-30.*
FDA Label Image

Principal Display Panel (5 mg Tablet Sachet Carton)

Principal Display Panel (5 mg Tablet Sachet Carton)
Packaging label for Zyprexa Zydis 5 mg orally disintegrating tablets, containing Olanzapine. The label indicates 30 sachets per package, with instructions for use illustrated. The product is distributed by H2-Pharma LLC and manufactured for CHEPLAPHARM. The label includes storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (10 mg Tablet Sachet Carton)

Principal Display Panel (10 mg Tablet Sachet Carton)
Packaging label for Zyprexa Zydis 10 mg orally disintegrating tablets by Cheplapharm, distributed by H2-Pharma LLC. The label shows the dosage form as oral disintegrating tablets, with presentation of 30 sachets. Instructions for opening the blister are illustrated, and storage temperature guidance is provided. The label also notes the medication guide dispensing requirement and phenylalanine content warning.*
FDA Label Image

Principal Display Panel (15 mg Tablet Sachet Carton)

Principal Display Panel (15 mg Tablet Sachet Carton)
Zyprexa Zydis 15 mg orally disintegrating tablets carton label with active ingredient Olanzapine. The label indicates 30 sachets per package, marked 15 mg strength, and includes storage and handling instructions. Distributed by H2-Pharma LLC and manufactured for Cheplapharm, the packaging features dosage and usage instructions with a yellow round tablet imprint visible in the design.*
FDA Label Image

Principal Display Panel (20 mg Tablet Sachet Carton)

Principal Display Panel (20 mg Tablet Sachet Carton)
Zyprexa Zydis 20 mg orally disintegrating tablets packaging label for a 30-sachet carton. The product contains olanzapine, labeled for oral use, distributed by H2-Pharma LLC and manufactured for CHEPLAPHARM. The label includes instructions for use, dosage strength, and storage information, along with trademark and registration details.*
FDA Label Image

Package Label (ZYPREXA INTRAMUSCULAR 10 mg/vial)

Package Label (ZYPREXA INTRAMUSCULAR 10 mg/vial)
Packaging label for Zyprexa Intramuscular Olanzapine Injection, 10 mg per vial. The label indicates a sterile single-dose vial for intramuscular use only. The labeler is H2-Pharma LLC, with licensing by CHEPLAPHARM Registration GmbH. It includes storage instructions, inactive ingredients, a barcode, and dosage preparation details, emphasizing the product is for human prescription use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.